Monocyte chemoattractant protein-1 (MCP-1) is a chemokine secreted by endothelial cells, smooth muscle cells? (SMC), and macrophages that plays a key role in recruiting macrophages to the arterial wall during the? development of atherosclerosis. Platelet-derived growth factor (PDGF) is an activator of SMC and a potent inducer? of MCP-1. The effect of PDGF on MCP-1 mRNA levels in SMC is due largely to a marked increase in mRNA? half-life (t1/2). In contrast, the glucocorticoid dexamethasone (Dex) inhibits the accumulation of MCP-1 mRNA in? a variety of cell types; in SMC this is due to a marked decrease in mRNA t1/2. The Dex effect appears to be? dependent upon the glucocorticoid receptor (GR), but not on new transcription, suggesting a novel role for the GR.? Although there is considerable information concerning the mechanisms by which PDGF and Dex regulate gene? transcription, far less is known about their effects on mRNA stability. This proposal will examine the mechanisms? by which PDGF and Dex regulate MCP-1 mRNA stability in cell culture and in vivo.
Aim 1 will characterize the? Dex-sensitive region of the MCP-1 mRNA, elucidate the mechanisms by which Dex destabilizes MCP-1 mRNA,? and identify the proteins involved. Emphasis will also be placed on establishing the role of the GR in regulating? MCP-1 mRNA stability. Similarly, aim 2 will characterize the mechanism by which PDGF enhances MCP-1? mRNA stability and identify the protein(s) involved.
Aim 3 will examine the regulation of MCP-1 mRNA stability? in animal models and will establish the effect of Dex on MCP-1-mediated events in vivo. It will also develop? animal models for examining mediators of MCP-1 mRNA stability identified in aims 1 and 2. These studies will? provide new insights into the regulation of MCP-1, the biology of PDGF and glucocorticoids, and the control of the? inflammatory response in the arterial wall. It may also provide novel approaches to inhibiting MCP-1 expression? and macrophage accumlation by mimicking the effect of Dex or by blocking the effect of PDGF on MCP-1 mRNA.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL077789-02
Application #
7429098
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2006-08-01
Project End
2010-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
2
Fiscal Year
2006
Total Cost
$416,476
Indirect Cost
Name
University of Rochester
Department
Type
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Heo, Kyung-Sun; Le, Nhat-Tu; Cushman, Hannah J et al. (2015) Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function. J Clin Invest 125:1299-310
Heo, Kyung-Sun; Fujiwara, Keigi; Abe, Jun-ichi (2014) Shear stress and atherosclerosis. Mol Cells 37:435-40
Le, Nhat-Tu; Heo, Kyung-Sun; Takei, Yuichiro et al. (2013) A crucial role for p90RSK-mediated reduction of ERK5 transcriptional activity in endothelial dysfunction and atherosclerosis. Circulation 127:486-99
Heo, Kyung-Sun; Chang, Eugene; Takei, Yuichiro et al. (2013) Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity. Arterioscler Thromb Vasc Biol 33:321-9
Knight, W E; Yan, C (2012) Cardiac cyclic nucleotide phosphodiesterases: function, regulation, and therapeutic prospects. Horm Metab Res 44:766-75
Wang, Xiao-Qun; Nigro, Patrizia; World, Cameron et al. (2012) Thioredoxin interacting protein promotes endothelial cell inflammation in response to disturbed flow by increasing leukocyte adhesion and repressing Kruppel-like factor 2. Circ Res 110:560-8
Dhawan, Latika; Liu, Bin; Pytlak, Allison et al. (2012) Y-box binding protein 1 and RNase UK114 mediate monocyte chemoattractant protein 1 mRNA stability in vascular smooth muscle cells. Mol Cell Biol 32:3768-75
Lim, Jae Hyang; Jono, Hirofumi; Komatsu, Kensei et al. (2012) CYLD negatively regulates transforming growth factor-?-signalling via deubiquitinating Akt. Nat Commun 3:771
Cai, Yujun; Knight, Walter E; Guo, Shujie et al. (2012) Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration. J Pharmacol Exp Ther 343:479-88
Le, Nhat-Tu; Takei, Yuichiro; Shishido, Tetsuro et al. (2012) p90RSK targets the ERK5-CHIP ubiquitin E3 ligase activity in diabetic hearts and promotes cardiac apoptosis and dysfunction. Circ Res 110:536-50

Showing the most recent 10 out of 50 publications